Macrogol 4000 Strides

Macrogol 4000, the active ingredient in Macrogol 4000 Strides, is an osmotic laxative presented as a powder for oral use. It is used to relieve constipation in adults and children by increasing water content in the intestinal lumen and facilitating bowel movements.

GNH USA supplies Macrogol 4000 Strides as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Macrogol 4000 Strides is an osmotic laxative indicated for the management of constipation and related functional bowel disorders. - Constipation: softens stool and promotes regular bowel movements. - Functional constipation: improves stool frequency and consistency in patients with chronic bowel sluggishness. - Occasional constipation: provides rapid relief of infrequent, hard stools without the need for stimulant agents.

Macrogol 4000 Strides may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating or distension. - Flatulence. - Nausea. - Mild abdominal cramping. - Diarrhoea, especially with higher doses. - Electrolyte imbalance (rare with short‑term use).

Serious or Rare Side Effects: - Severe dehydration. - Persistent diarrhoea leading to electrolyte disturbances. - Allergic reactions such as rash, urticaria, or angioedema. - Abdominal pain that does not resolve. - Signs of intestinal obstruction. - Unexpected weight loss.

Before using Macrogol 4000 Strides, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential risks with a physician. - Renal impairment: monitor fluid and electrolyte balance. - Gastrointestinal obstruction: avoid use if a blockage is suspected. - Chronic diarrhoea: discontinue if symptoms persist. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Macrogol 4000 may interact with other medications or substances that affect fluid balance or gastrointestinal motility.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of hyperkalaemia. - Lithium: altered lithium levels due to changes in renal clearance. - Antacids containing magnesium or aluminium: may reduce laxative efficacy.

Moderate Interactions (Monitor Closely): - Other osmotic laxatives: additive effect may cause severe diarrhoea. - Oral antibiotics: possible reduced absorption of the antibiotic. - Anticoagulants: monitor for changes in plasma volume that could affect dosing.